IOL CHEMICALS & PHARM. | WINDLAS BIOTECH | IOL CHEMICALS & PHARM./ WINDLAS BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 21.9 | 60.0% | View Chart |
P/BV | x | 1.5 | 2.9 | 51.8% | View Chart |
Dividend Yield | % | 1.0 | 0.7 | 144.3% |
IOL CHEMICALS & PHARM. WINDLAS BIOTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
WINDLAS BIOTECH Mar-23 |
IOL CHEMICALS & PHARM./ WINDLAS BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 280 | 191.7% | |
Low | Rs | 272 | 203 | 134.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 245.1 | 154.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 20.4 | 116.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 26.3 | 120.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 4.00 | 100.0% | |
Avg Dividend yield | % | 1.0 | 1.7 | 59.7% | |
Book value per share (Unadj.) | Rs | 256.8 | 190.9 | 134.6% | |
Shares outstanding (eoy) | m | 58.71 | 20.93 | 280.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.0 | 108.7% | |
Avg P/E ratio | x | 17.1 | 11.9 | 143.9% | |
P/CF ratio (eoy) | x | 12.8 | 9.2 | 139.4% | |
Price / Book Value ratio | x | 1.6 | 1.3 | 124.4% | |
Dividend payout | % | 16.9 | 19.6 | 85.9% | |
Avg Mkt Cap | Rs m | 23,743 | 5,055 | 469.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 703 | 239.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 5,131 | 432.1% | |
Other income | Rs m | 256 | 100 | 257.0% | |
Total revenues | Rs m | 22,427 | 5,230 | 428.8% | |
Gross profit | Rs m | 2,257 | 602 | 374.7% | |
Depreciation | Rs m | 462 | 124 | 373.3% | |
Interest | Rs m | 165 | 8 | 2,090.1% | |
Profit before tax | Rs m | 1,887 | 570 | 330.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 144 | 343.5% | |
Profit after tax | Rs m | 1,391 | 426 | 326.4% | |
Gross profit margin | % | 10.2 | 11.7 | 86.7% | |
Effective tax rate | % | 26.2 | 25.3 | 103.9% | |
Net profit margin | % | 6.3 | 8.3 | 75.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 3,535 | 273.4% | |
Current liabilities | Rs m | 5,025 | 1,212 | 414.5% | |
Net working cap to sales | % | 20.9 | 45.3 | 46.2% | |
Current ratio | x | 1.9 | 2.9 | 66.0% | |
Inventory Days | Days | 43 | 111 | 39.1% | |
Debtors Days | Days | 8 | 83 | 10.0% | |
Net fixed assets | Rs m | 11,017 | 1,734 | 635.3% | |
Share capital | Rs m | 587 | 105 | 561.1% | |
"Free" reserves | Rs m | 14,490 | 3,890 | 372.5% | |
Net worth | Rs m | 15,077 | 3,995 | 377.4% | |
Long term debt | Rs m | 0 | 1 | 0.0% | |
Total assets | Rs m | 20,684 | 5,270 | 392.5% | |
Interest coverage | x | 12.5 | 73.4 | 17.0% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.0 | 110.1% | |
Return on assets | % | 7.5 | 8.2 | 91.3% | |
Return on equity | % | 9.2 | 10.7 | 86.5% | |
Return on capital | % | 13.6 | 14.5 | 94.0% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 218 | 2,722.2% | |
Fx outflow | Rs m | 6,052 | 68 | 8,906.3% | |
Net fx | Rs m | -122 | 150 | -81.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 610 | 200.6% | |
From Investments | Rs m | -1,200 | -141 | 850.5% | |
From Financial Activity | Rs m | -41 | -437 | 9.4% | |
Net Cashflow | Rs m | -18 | 31 | -59.1% |
Indian Promoters | % | 48.2 | 62.8 | 76.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 13.0 | 13.1% | |
FIIs | % | 1.4 | 1.2 | 118.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 37.2 | 139.3% | |
Shareholders | 130,003 | 51,277 | 253.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | WINDLAS BIOTECH | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | 6.97% | -0.44% |
1-Month | -4.51% | 9.26% | 2.15% |
1-Year | -4.09% | 122.15% | 49.82% |
3-Year CAGR | -12.01% | 10.92% | 14.21% |
5-Year CAGR | 15.35% | 6.42% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the WINDLAS BIOTECH share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of WINDLAS BIOTECH the stake stands at 62.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of WINDLAS BIOTECH.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
WINDLAS BIOTECH paid Rs 4.0, and its dividend payout ratio stood at 19.6%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of WINDLAS BIOTECH.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.